zaprinast and 5-nitro-2-(3-phenylpropylamino)benzoic-acid

zaprinast has been researched along with 5-nitro-2-(3-phenylpropylamino)benzoic-acid* in 2 studies

Other Studies

2 other study(ies) available for zaprinast and 5-nitro-2-(3-phenylpropylamino)benzoic-acid

ArticleYear
5-Nitro-2-(3-phenylpropylamino)benzoic acid is a GPR35 agonist.
    Pharmacology, 2008, Volume: 82, Issue:4

    GPR35 is a Gi/o- and G16-coupled receptor abundantly expressed in gastrointestinal tissues and immune cells. Kynurenic acid (a tryptophan metabolite and ionotropic glutamate receptor antagonist) and zaprinast (a phosphodiesterase inhibitor) are GPR35 agonists. Here, we show that the chloride channel blocker 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) is also a GPR35 agonist. NPPB activates the GPR35-Gi/o and GPR35-G16 pathways in human embryonic kidney 293 (HEK293) cells and induces intracellular calcium mobilization in a concentration-dependent manner in HEK293 cells coexpressing human, rat or mouse GPR35 and the chimeric G protein G(qi5). These results suggest a novel pharmacological activity of NPPB and will provide useful information to search for more potent and selective GPR35 agonists.

    Topics: Animals; Cell Line; Chloride Channels; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Kidney; Mice; Nitrobenzoates; Purinones; Rats; Receptors, G-Protein-Coupled

2008
Effects of 5-nitro-2-(3-phenylpropylamino) benzoic acid, anthracene-9-carboxylate, and zaprinast on endothelin-1-induced contractions of pregnant rat myometrium.
    European journal of obstetrics, gynecology, and reproductive biology, 2002, Nov-15, Volume: 105, Issue:2

    The effects of 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB), anthracene-9-carboxylate (9-AC) (chloride channel blockers) and zaprinast (an inhibitor of phosphodiesterase-5) on endothelin-1 (ET-1) induced contractions of pregnant rat myometrium were investigated in vitro.. Isolated myometrial strips were obtained from pregnant rats, and the strips were mounted in organ baths for recording of isometric tension (n=8). The effects of 10(-7) to 10(-4)M NPPB, 10(-7) to 10(-4)M 9-AC, and 10(-7) to 10(-4)M zaprinast on 10(-8)M ET-1-induced contractions of pregnant rat myometrial smooth muscle were recorded.. NPPB and 9-AC increased the amplitude of ET-1-induced myometrial contractions, while decreasing the frequency, in a concentration-dependent manner. The amplitude of myometrial contractions were significantly increased by NPPB and 9-AC beginning from the concentration of 10(-6)M. The frequency of myometrial contractions were significantly decreased by NPPB and 9-AC beginning from the concentration of 10(-6)M. Zaprinast inhibited the amplitude and frequency of ET-1-induced myometrial contractions in a concentration-dependent manner. Zaprinast-induced decreases in amplitude and frequency of myometrial contractions reached statistical significance beginning from the concentrations of 10(-7)M and 10(-5)M, respectively.. These data provide evidence that the ET-1-induced contractions of pregnant rat myometrial strips may be modulated by chloride channels. In addition, zaprinast effectively inhibited ET-1-induced contractions in pregnant rat myometrium.

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Anthracenes; Calcium; Chloride Channels; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelin-1; Female; Myometrium; Nitrobenzoates; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pregnancy; Purinones; Rats; Rats, Wistar; Uterine Contraction

2002